Volgen
Charles B. Holmes
Charles B. Holmes
Georgetown Center for Innovation in Global Health
Geverifieerd e-mailadres voor georgetown.edu - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
The epidemiology of DSM-III-R bipolar I disorder in a general population survey
RC Kessler, DR Rubinow, C Holmes, JM Abelson, S Zhao
Bipolar Disorder, 11-21, 2019
7972019
Towards an improved investment approach for an effective response to HIV/AIDS
B Schwartländer, J Stover, T Hallett, R Atun, C Avila, E Gouws, M Bartos, ...
The Lancet 377 (9782), 2031-2041, 2011
6382011
A review of sex differences in the epidemiology of tuberculosis
CB Holmes, H Hausler, P Nunn
The International Journal of Tuberculosis and Lung Disease 2 (2), 96-104, 1998
5971998
Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa
CB Holmes, E Losina, RP Walensky, Y Yazdanpanah, KA Freedberg
Clinical infectious diseases 36 (5), 652-662, 2003
4062003
Tenofovir disoproxil fumarate, emtricitabine, and efavirenz compared with zidovudine/lamivudine and efavirenz in treatment-naive patients: 144-week analysis
JR Arribas, AL Pozniak, JE Gallant, E DeJesus, B Gazzard, RE Campo, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 47 (1), 74-78, 2008
3332008
Cost-effectiveness of HIV treatment in resource-poor settings—the case of Côte d'Ivoire
SJ Goldie, Y Yazdanpanah, E Losina, MC Weinstein, X Anglaret, ...
New England Journal of Medicine 355 (11), 1141-1153, 2006
3322006
CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment
CB Holmes, R Wood, M Badri, S Zilber, B Wang, G Maartens, H Zheng, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (4), 464-469, 2006
2552006
Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050
R Granich, JG Kahn, R Bennett, CB Holmes, N Garg, C Serenata, ...
PloS one 7 (2), e30216, 2012
2012012
Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics
MM Kavanagh, NA Erondu, O Tomori, VJ Dzau, EA Okiro, A Maleche, ...
The Lancet 395 (10238), 1735-1738, 2020
2002020
HIV development assistance and adult mortality in Africa
E Bendavid, CB Holmes, J Bhattacharya, G Miller
Jama 307 (19), 2060-2067, 2012
1972012
Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting
M Shah, E Variava, CB Holmes, A Coppin, JE Golub, J McCallum, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 52 (2), 145-151, 2009
1922009
Reframing HIV care: putting people at the centre of antiretroviral delivery
C Duncombe, S Rosenblum, N Hellmann, C Holmes, L Wilkinson, M Biot, ...
Tropical Medicine & International Health 20 (4), 430-447, 2015
1862015
Sustainable HIV treatment in Africa through viral-load-informed differentiated care
A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ...
Nature 528 (7580), S68-S76, 2015
1672015
Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR)
NS Padian, CB Holmes, SI McCoy, R Lyerla, PD Bouey, EP Goosby
JAIDS Journal of Acquired Immune Deficiency Syndromes 56 (3), 199-203, 2011
1502011
Scale-up of HIV treatment through PEPFAR: a historic public health achievement
WM El-Sadr, CB Holmes, P Mugyenyi, H Thirumurthy, T Ellerbrock, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 60, S96-S104, 2012
1352012
Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs
CB Holmes, W Coggin, D Jamieson, H Mihm, R Granich, P Savio, M Hope, ...
JAMA 304 (3), 313-320, 2010
1242010
HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
PLoS Medicine 9 (7), e1001259, 2012
992012
A review of differentiated service delivery for HIV treatment: effectiveness, mechanisms, targeting, and scale
M Roy, C Bolton Moore, I Sikazwe, CB Holmes
Current HIV/AIDS Reports 16, 324-334, 2019
912019
HIV drug resistance in low-income and middle-income countries
RL Hamers, TFR de Wit, CB Holmes
The Lancet HIV 5 (10), e588-e596, 2018
862018
Understanding preferences for HIV care and treatment in Zambia: evidence from a discrete choice experiment among patients who have been lost to follow-up
A Zanolini, K Sikombe, I Sikazwe, I Eshun-Wilson, P Somwe, ...
PLoS medicine 15 (8), e1002636, 2018
862018
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20